Coco, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 4.030
EU - Europa 3.668
AS - Asia 3.319
SA - Sud America 575
AF - Africa 96
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 11.707
Nazione #
US - Stati Uniti d'America 3.932
SG - Singapore 1.492
DE - Germania 1.438
CN - Cina 806
SE - Svezia 534
IT - Italia 499
BR - Brasile 476
FR - Francia 304
VN - Vietnam 272
UA - Ucraina 202
IN - India 185
GB - Regno Unito 159
IE - Irlanda 145
JP - Giappone 92
ID - Indonesia 91
FI - Finlandia 87
TR - Turchia 72
HK - Hong Kong 69
RU - Federazione Russa 67
BD - Bangladesh 47
PL - Polonia 46
MX - Messico 44
AT - Austria 38
BE - Belgio 37
NL - Olanda 36
CA - Canada 35
AR - Argentina 34
IQ - Iraq 34
ZA - Sudafrica 27
KR - Corea 20
PK - Pakistan 20
PH - Filippine 14
ES - Italia 13
UZ - Uzbekistan 13
VE - Venezuela 13
EC - Ecuador 12
SA - Arabia Saudita 12
CI - Costa d'Avorio 11
AE - Emirati Arabi Uniti 10
CO - Colombia 10
CZ - Repubblica Ceca 10
KE - Kenya 10
RO - Romania 10
LT - Lituania 9
PE - Perù 9
JO - Giordania 8
TN - Tunisia 8
AU - Australia 7
CL - Cile 7
DZ - Algeria 7
MA - Marocco 7
ET - Etiopia 6
IL - Israele 6
IR - Iran 6
LV - Lettonia 6
MY - Malesia 6
UY - Uruguay 6
EG - Egitto 5
KZ - Kazakistan 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
JM - Giamaica 4
NG - Nigeria 4
NP - Nepal 4
AM - Armenia 3
BB - Barbados 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
AL - Albania 2
BW - Botswana 2
CR - Costa Rica 2
CY - Cipro 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
OM - Oman 2
PG - Papua Nuova Guinea 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AQ - Antartide 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
Totale 11.694
Città #
Singapore 799
Chandler 571
San Jose 403
Ashburn 367
Beijing 165
Dublin 145
New York 123
Ann Arbor 121
Jacksonville 120
San Mateo 101
Lauterbourg 98
Ho Chi Minh City 96
Los Angeles 90
Milan 88
Hefei 87
Tokyo 85
Nanjing 84
Jakarta 80
Munich 74
Nürnberg 70
Wilmington 67
Cattolica 65
Frankfurt am Main 62
Hong Kong 61
Hanoi 58
São Paulo 58
Hyderabad 57
Boston 52
Marseille 51
Houston 50
Izmir 49
Rome 46
Dearborn 42
Dallas 41
Princeton 40
Brussels 36
Moscow 35
Woodbridge 35
Chicago 34
Lawrence 31
Santa Clara 31
The Dalles 31
Nanchang 30
Redwood City 28
Buffalo 26
Bremen 25
Orem 25
Seattle 24
Brooklyn 22
Nuremberg 22
St Louis 22
Stockholm 22
Helsinki 21
Kent 21
London 21
Warsaw 21
Da Nang 20
Council Bluffs 19
Fairfield 19
Seoul 19
Vienna 19
Norwalk 18
Zhengzhou 18
Atlanta 17
Baghdad 16
Boardman 16
Denver 16
Johannesburg 16
Lancaster 16
Phoenix 16
San Francisco 16
Shenyang 16
Turku 16
Shanghai 15
Düsseldorf 14
Haiphong 14
Tianjin 14
Belo Horizonte 13
Guangzhou 13
Hebei 13
Kunming 13
Mountain View 13
Tashkent 13
Chennai 12
Columbus 12
Jiaxing 12
Rio de Janeiro 12
Abidjan 11
Brasília 11
Curitiba 11
Lappeenranta 11
Leawood 11
Paris 11
Washington 11
Changsha 10
Detroit 10
Kraków 10
Mexico City 10
Poplar 10
Toronto 10
Totale 5.742
Nome #
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 505
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 268
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 231
Protective ileostomy creation after anterior resection of the rectum (PICARR): a decision-making exploring international survey 217
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 217
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 190
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 186
Polyvinylidene Fluoride Mesh (PVDF, DynaMesh®-IPOM) in The Laparoscopic Treatment of Incisional Hernia: A Prospective Comparative Trial versus Gore® ePTFE DUALMESH® Plus. 182
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 181
Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection 178
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 178
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 177
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 175
Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli 175
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 174
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 172
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 170
Advance in diagnosis and treatment of small bowel tumors: a single-center report 159
Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? 151
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 150
BRIDGE -1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial 148
The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes 148
Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience. 145
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 144
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 143
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 140
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 140
[D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium 139
Familial microsatellite-stable non-polyposis colorectal cancer: incidence and characteristics in a clinic-based population 138
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 138
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 136
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 136
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 133
Tumor size as a prognostic factor in patients with stage IIa colon cancer 133
Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study 132
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 130
Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. 129
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 127
CT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. 126
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 125
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 125
Effectiveness and Validation of the Italian Translation of the Low Anterior Resection Syndrome Score in an Italian High-Volume University Hospital 118
Anastomosis configuration and technique following ileocaecal resection for Crohn’s disease: a multicentre study 118
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 117
RESTAGING LOCALLY ADVANCED RECTAL CANCER WITH MR IMAGING AFTER CHEMORADIATION THERAPY 114
Preoperative chemoradiotherapy affects postoperative outcomes and functional results in patients treated with transanal endoscopic microsurgery for rectal neoplasms 114
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 113
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 110
LONG-TERM RESULTS AFTER NEOADJUVANT RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED RESECTABLE EXTRAPERITONEAL RECTAL CANCER. 110
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 109
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 106
Surgical treatment of small bowel neoplasms. 104
Four steps in the evolution of rectal cancer managements through 40 years of clinical practice: Pioneering, standardization, challenges and personalization 101
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper. 100
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 99
Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study 99
Body mass index and complications following major gastrointestinal surgery: A prospective, international cohort study and meta-analysis 98
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) 96
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 95
Rectal Sparing Approach after preoperative Radio- and/or Chemo-therapy (ReSARCh): a prospective, multicenter, observational study 95
Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 95
Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients 94
Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: Report of a case and review of the literature 94
National variations in perioperative assessment and surgical management of Crohn’s disease: a multicentre study 94
Correction to: Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer (Annals of Surgical Oncology, (2021), 28, 5, (2801-2808), 10.1245/s10434-020-09243-6) 94
The 2017 Assisi Think Tank Meeting on rectal cancer: A positioning paper 93
Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer 92
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial 91
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer 91
T1 colon cancer in the era of screening: risk factors and treatment 91
Practice parameters for early rectal cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines 89
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial 88
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 87
Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. 86
Neutrophil to lymphocyte ratio predicts risk of nodal involvement in T1 colorectal cancer patients 84
Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-Colorectal Cancer Network (SICO-CNN) 83
Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group 80
Association of Delayed Surgery with Oncologic Long-term Outcomes in Patients with Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation 79
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer 79
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer after Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome 78
Textbook Outcome in Colorectal Surgery for Cancer: An Italian Version 77
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer 76
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 76
Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients 76
Role and Morbidity of Protective Ileostomy after Anterior Resection for Rectal Cancer: One Centre Experience and Review of Literature 76
Global variation in the long-term outcomes of ypT0 rectal cancers 75
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 74
Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: Prognostic factors and long term outcome 72
Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications 71
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis 70
Laparoscopic approach to recurrent incisional hernia repair: A 3-year experience 68
Segmental Colonic Resection Is a Safe and Effective Treatment Option for Colon Cancer of the Splenic Flexure: A Nationwide Retrospective Study of the Italian Society of Surgical Oncology-Colorectal Cancer Network Collaborative Group 66
Selection of locally advanced gastric carcinoma by preoperative staging laparoscopy 63
Surgeons' fear of getting infected by COVID19: A global survey 59
Split course concomitant radiochemotherapy followed by brachytherapy boost in the exclusive treatment of the anal canal cancer 53
Combined-modality therapy in locally advanced primary rectal cancer 45
The prognostic role of anatomo-pathological factors in colorectal cancer: an univariate analysis 44
Other tumours of the colon and rectum 35
Rectal sparing approach after preoperative radio - and/or Chemo-therapy (ReSARCh): a prospective, multicentre, observational study 27
Totale 11.872
Categoria #
all - tutte 45.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.788


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 0 69 15
2021/2022717 62 39 12 87 29 30 8 93 21 49 155 132
2022/20231.478 216 212 93 248 79 189 75 121 165 20 33 27
2023/2024691 38 206 20 50 46 112 27 10 8 18 80 76
2024/20251.798 26 45 130 72 210 78 84 81 226 194 353 299
2025/20264.688 675 138 298 515 811 569 746 231 295 346 64 0
Totale 11.872